We present the case of a 52-year-old man with human immunodeficiency virus (HIV) encephalitis resulting from cerebrospinal fluid (CSF) viral escape, to illustrate therapeutic challenges in patients with emergent CSF genotypic HIV drug resistance. This case report highlights the usefulness of CSF HIV-resistance testing to guide antiretroviral therapy and treatment optimizing decisions.
LetendreSMarquie-BeckJCapparelliEet al.
Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol2008;
65: 65–70.
WendelKAMcArthurJC.Acute meningoencephalitis in chronic human immunodeficiency virus (HIV) infection: putative central nervous system escape of HIV replication. Clin Infect Dis2003;
37: 1107–1111.
5.
CanestriALescureFXJaureguiberrySet al.
Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin Infect Dis2010;
50: 773–778.
6.
BinghamRAhmedNRangiPet al.
HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape. Int J STD AIDS2011;
22: 608–609.
7.
DinhASalomonJDuDLet al.
Meningoencephalitis due to HIV replication despite plasmatic viral control. J Int Assoc Physicians AIDS Care (Chic)2011;
10: 345–348.
8.
MangioniDMuscatelloASabbatiniFet al.
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: worth the risk?Clin Infect Dis2014;
59: 1655–1656.
